# Immunovant, Inc.: Form 8-K, filed Aug 13, 2024

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 8-K
- Filed: 2024-08-13
- Accepted by EDGAR: Aug 13, 2024, 16:12 ET
- Period: 2024-08-12
- Accession: 0001764013-24-000150
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401324000150/imvt-20240812.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401324000150/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401324000150/imvt-20240812.htm

Filed Aug 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001764013-24-000150. Last ingested by Listed: Nov 9, 2026, 17:43 ET. No prices; not investment advice.